Armata Pharmaceuticals, Inc.
ARMP- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000921114
No open-market purchases or sales by Armata Pharmaceuticals, Inc. insiders were filed in the last 90 days; 53 institutions reported holding it in 13F filings for Q2 2026, worth $32.3M in total; no superinvestor holds it.
Q4 2022 vs. Q3 2022
How the institutions holding Armata Pharmaceuticals, Inc. changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Q4 2022 | Change |
|---|---|---|---|
| Holders | 20 | 26 | +6 |
| Shares | 1.36M | 1.30M | −55.0K (−4.1%) |
| Value | $5.73M | $1.61M | −$4.12M (−71.8%) |
New holders (9)
Institutions that held Armata Pharmaceuticals, Inc. at the end of Q4 2022 but not at the end of Q3 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| HRT Financial LP | 42,277 | $52.0K | 0.00% |
| Ergoteles LLC | 27,941 | $34.6K | 0.00% |
| Jane Street Group, LLC | 20,024 | $24.8K | 0.00% |
| Millennium Management LLC | 15,585 | $19.0K | 0.00% |
| Goldman Sachs Group Inc | 13,907 | $17.2K | 0.00% |
| Citadel Advisors LLC | 12,162 | $15.1K | 0.00% |
| Susquehanna International Group, LLP | 10,247 | $12.7K | 0.00% |
| U.S. Capital Wealth Advisors, LLC | 4,000 | $4.96K | 0.00% |
| Trifecta Capital Advisors, LLC | 714 | $885 | 0.00% |
Sold out (3)
Institutions that held Armata Pharmaceuticals, Inc. at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Synovus Financial Corp | 47,903 | $202.0K |
| Advisor Group Holdings, Inc. | 5,500 | $23.0K |
| Royal Bank of Canada | 134 | $1.00K |